Capmatinib in MET Exon 14-mutated or MET-amplified non-small-cell lung cancer

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wolf, Jürgen (VerfasserIn) , Thomas, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 3, 2020
In: The New England journal of medicine
Year: 2020, Jahrgang: 383, Heft: 10, Pages: 944-957
ISSN:1533-4406
DOI:10.1056/NEJMoa2002787
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa2002787
Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa2002787
Volltext
Verfasserangaben:J. Wolf, T. Seto, J.-Y. Han, N. Reguart, E.B. Garon, H.J.M. Groen, D.S.W. Tan, T. Hida, M. de Jonge, S.V. Orlov, E.F. Smit, P.-J. Souquet, J. Vansteenkiste, M. Hochmair, E. Felip, M. Nishio, M. Thomas, K. Ohashi, R. Toyozawa, T.R. Overbeck, F. de Marinis, T.-M. Kim, E. Laack, A. Robeva, S. Le Mouhaer, M. Waldron-Lynch, B. Sankaran, O.A. Balbin, X. Cui, M. Giovannini, M. Akimov, and R.S. Heist, for the GEOMETRY mono-1 Investigators

MARC

LEADER 00000caa a2200000 c 4500
001 1747702579
003 DE-627
005 20230426111217.0
007 cr uuu---uuuuu
008 210205s2020 xx |||||o 00| ||eng c
024 7 |a 10.1056/NEJMoa2002787  |2 doi 
035 |a (DE-627)1747702579 
035 |a (DE-599)KXP1747702579 
035 |a (OCoLC)1341391922 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wolf, Jürgen  |e VerfasserIn  |0 (DE-588)1168606233  |0 (DE-627)1032369337  |0 (DE-576)511629168  |4 aut 
245 1 0 |a Capmatinib in MET Exon 14-mutated or MET-amplified non-small-cell lung cancer  |c J. Wolf, T. Seto, J.-Y. Han, N. Reguart, E.B. Garon, H.J.M. Groen, D.S.W. Tan, T. Hida, M. de Jonge, S.V. Orlov, E.F. Smit, P.-J. Souquet, J. Vansteenkiste, M. Hochmair, E. Felip, M. Nishio, M. Thomas, K. Ohashi, R. Toyozawa, T.R. Overbeck, F. de Marinis, T.-M. Kim, E. Laack, A. Robeva, S. Le Mouhaer, M. Waldron-Lynch, B. Sankaran, O.A. Balbin, X. Cui, M. Giovannini, M. Akimov, and R.S. Heist, for the GEOMETRY mono-1 Investigators 
264 1 |c September 3, 2020 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.02.2021 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
773 0 8 |i Enthalten in  |t The New England journal of medicine  |d Waltham, Mass. : MMS, 1928  |g 383(2020), 10, Seite 944-957  |h Online-Ressource  |w (DE-627)266889484  |w (DE-600)1468837-2  |w (DE-576)075962454  |x 1533-4406  |7 nnas  |a Capmatinib in MET Exon 14-mutated or MET-amplified non-small-cell lung cancer 
773 1 8 |g volume:383  |g year:2020  |g number:10  |g pages:944-957  |g extent:14  |a Capmatinib in MET Exon 14-mutated or MET-amplified non-small-cell lung cancer 
856 4 0 |u https://doi.org/10.1056/NEJMoa2002787  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nejm.org/doi/10.1056/NEJMoa2002787  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210205 
993 |a Article 
994 |a 2020 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 50000  |e 50000PT1054438781  |k 0/50000/  |p 17 
999 |a KXP-PPN1747702579  |e 3849520560 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["J. Wolf, T. Seto, J.-Y. Han, N. Reguart, E.B. Garon, H.J.M. Groen, D.S.W. Tan, T. Hida, M. de Jonge, S.V. Orlov, E.F. Smit, P.-J. Souquet, J. Vansteenkiste, M. Hochmair, E. Felip, M. Nishio, M. Thomas, K. Ohashi, R. Toyozawa, T.R. Overbeck, F. de Marinis, T.-M. Kim, E. Laack, A. Robeva, S. Le Mouhaer, M. Waldron-Lynch, B. Sankaran, O.A. Balbin, X. Cui, M. Giovannini, M. Akimov, and R.S. Heist, for the GEOMETRY mono-1 Investigators"]},"title":[{"title_sort":"Capmatinib in MET Exon 14-mutated or MET-amplified non-small-cell lung cancer","title":"Capmatinib in MET Exon 14-mutated or MET-amplified non-small-cell lung cancer"}],"origin":[{"dateIssuedDisp":"September 3, 2020","dateIssuedKey":"2020"}],"id":{"eki":["1747702579"],"doi":["10.1056/NEJMoa2002787"]},"person":[{"given":"Jürgen","family":"Wolf","role":"aut","display":"Wolf, Jürgen"},{"family":"Thomas","display":"Thomas, Michael","role":"aut","given":"Michael"}],"note":["Gesehen am 05.02.2021"],"language":["eng"],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"NEJM"}],"note":["Gesehen am 04.08.25"],"corporate":[{"role":"isb","display":"Massachusetts Medical Society"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"266889484","title":[{"title_sort":"New England journal of medicine","title":"The New England journal of medicine","subtitle":"NEJM"}],"disp":"Capmatinib in MET Exon 14-mutated or MET-amplified non-small-cell lung cancerThe New England journal of medicine","name":{"displayForm":["Massachusetts Medical Society"]},"origin":[{"dateIssuedDisp":"1928-","publisher":"MMS ; MMS","publisherPlace":"Waltham, Mass. ; Boston, Mass.","dateIssuedKey":"1928"}],"id":{"zdb":["1468837-2"],"issn":["1533-4406"],"eki":["266889484"]},"part":{"pages":"944-957","text":"383(2020), 10, Seite 944-957","year":"2020","volume":"383","extent":"14","issue":"10"},"pubHistory":["198.1928 -"],"language":["eng"]}],"physDesc":[{"extent":"14 S."}],"recId":"1747702579"} 
SRT |a WOLFJUERGECAPMATINIB3202